Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Vibegron is an agonist of the β3-adrenergic receptor (β3-AR).1 It selectively induces cAMP accumulation in cells expressing β3-ARs (EC50 = 2 nM) over β1- or β2-ARs for which it has no activity at 10 µM. Vibegron (3 mg/kg, i.v.) increases the micturition interval and decreases the micturition pressure in a female rat model of Parkinson’s disease with lower urinary tract (LUT) dysfunction.2 It reduces non-voiding contractions during bladder filling in mice with spinal cord injury.3 Formulations containing vibegron have been used in the treatment of overactive bladder.
WARNING This product is not for human or veterinary use.
1. Selectivity and maximum response of vibegron and mirabegron for β3-
2. Effects of a new selective β3-
3. Efficacy of vibegron, a novel β3-